SAN DIEGO--(BUSINESS WIRE)--Batu Biologics, a biotechnology company focusing on developing therapies that target the Achilles Heel of Cancer: the tumor blood vessels, announced today the filing of an ...

Batu Biologics has raised $1 million to develop its lung cancer immune therapy, the two-year-old San Diego company said Wednesday. The therapy, ValloVax, is intended to stimulate an immune response ...

International Biotech Market Expert Will Help Boost Company's Business Strategy SAN DIEGO--(BUSINESS WIRE)--Batu Biologics, an immunotherapy company working to develop ValloVax™, the first cellular ...

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics, a clinical stage immuno-oncology Company, announced today the filing of a patent application covering methods of selecting patients likely to respond to ...

San Diego’s Batu Biologics said Monday that it has received regulatory permission to begin human testing of its cancer immunotherapy, ValloVax. The therapy is designed to inhibit the growth of new ...

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics, a San Diego based immunotherapy company working to develop therapeutics targeting the tumor vasculature, announced today the appointment of Gerry Berg as ...

Using a fundraising approach seldom seen in the life sciences sector, Batu Biologics, an immunotherapy company working to develop the first anti-angiogenic cancer vaccine, has successfully raised $100 ...

Batu Biologics, an immuno-oncology company focused on the development and commercialization of novel therapies, announced on Monday the closing of its Regulation 506(c) equity crowdfunding offering on ...

SAN DIEGO, May 3, 2019 /PRNewswire/ -- Batu Biologics Inc. announced today the appointment of Dr. Thomas Ichim to the position of its President and Chief Executive Officer. Dr. Ichim has a track ...

San Diego-based Batu Biologics, a developer of immune therapy drugs aimed at treating cancer, has added investor John Peck Jr. to its Board of Directors. The company said Peck has been involved with ...